Cargando…
Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial
BACKGROUND: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure. Although angiotensin II receptor blockers (ARBs) can be used to attenuate proteinuria in DN patients, their efficacy remains limited. This clinical trial aimed to evaluate the efficacy of Tripterygium wilfordi...
Autores principales: | Ge, Yongchun, Xie, Honglang, Li, Shijun, Jin, Bo, Hou, Jinhua, Zhang, Haitao, Shi, Mingjun, Liu, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670993/ https://www.ncbi.nlm.nih.gov/pubmed/23725518 http://dx.doi.org/10.1186/1479-5876-11-134 |
Ejemplares similares
-
Tripterygium wilfordii Hook F Treatment for Stage IV Diabetic Nephropathy: Protocol for a Prospective, Randomized Controlled Trial
por: Lengnan, Xu, et al.
Publicado: (2020) -
The complete chloroplast genome of Tripterygium wilfordii Hook. f. (Celastraceae)
por: Zhong, Yuan, et al.
Publicado: (2022) -
Immunosuppressive Sesquiterpene Pyridine Alkaloids from Tripterygium wilfordii Hook. f.
por: Wang, Yadan, et al.
Publicado: (2022) -
Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases
por: Tong, Xue, et al.
Publicado: (2022) -
Tripterygium wilfordii Hook. f. Preparations for Rheumatoid Arthritis: An Overview of Systematic Reviews
por: Li, Huimin, et al.
Publicado: (2022)